Stay updated on Efgartigimod SubQ in Idiopathic Inflammatory Myopathy Clinical Trial

Sign up to get notified when there's something new on the Efgartigimod SubQ in Idiopathic Inflammatory Myopathy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Efgartigimod SubQ in Idiopathic Inflammatory Myopathy Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The ClinicalTrials.gov page’s displayed site revision changed from v3.8.0 to v3.8.1.
    Difference
    0.0%
    Check dated 2026-11-21T15:12:19.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    14 days ago
    Change Detected
    Summary
    The clinical trial record for the long-term efgartigimod study is displayed, including its eligibility criteria, study design and outcomes, and participating locations. The prior access-denied error is no longer shown.
    Difference
    83%
    Check dated 2026-11-07T14:54:44.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden message with a Home link. The site revision changed from v3.7.2 to v3.8.0.
    Difference
    0.6%
    Check dated 2026-10-31T15:45:43.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    A site-wide NIH notice about using “Super Intelligence” in place of “Artificial Intelligence” appears above the unchanged 403 error page.
    Difference
    1%
    Check dated 2026-10-24T18:49:22.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.1 to v3.7.2 on the ClinicalTrials.gov 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-17T18:24:25.000Z thumbnail image
  7. Check
    42 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page footer now displays revision v3.7.1 instead of v3.7.0.
    Difference
    0.2%
    Check dated 2026-10-10T19:12:58.000Z thumbnail image

Stay in the know with updates to Efgartigimod SubQ in Idiopathic Inflammatory Myopathy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Efgartigimod SubQ in Idiopathic Inflammatory Myopathy Clinical Trial page.